Bristol-Myers Squibb Co
SWB:BRM
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
B
|
Bristol-Myers Squibb Co
SWB:BRM
|
US |
|
Netflix Inc
NASDAQ:NFLX
|
US |
|
Systemair AB
STO:SYSR
|
SE |
|
M
|
Murphy Oil Corp
F:MUQ
|
US |
|
Valneva SE
NASDAQ:VALN
|
FR |
|
W
|
W R Berkley Corp
F:WR1
|
US |
|
Renaissancere Holdings Ltd
F:RRJ
|
BM |
|
AxoGen Inc
NASDAQ:AXGN
|
US |
|
C
|
Caterpillar Inc
PAR:CATR
|
US |
|
Wyndham Hotels & Resorts Inc
NYSE:WH
|
US |
|
Kokuyo Co Ltd
TSE:7984
|
JP |
|
Adicet Bio Inc
NASDAQ:ACET
|
US |
|
Technip Energies NV
LSE:0A8A
|
FR |
|
Kimberly-Clark de Mexico SAB de CV
OTC:KCDMF
|
MX |
Wall St Price Targets
BRM Price Targets Summary
Bristol-Myers Squibb Co
According to Wall Street analysts, the average 1-year price target for BRM is 54.979 EUR with a low forecast of 29.092 EUR and a high forecast of 68.53 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is BRM's stock price target?
Price Target
54.979
EUR
According to Wall Street analysts, the average 1-year price target for BRM is 54.979 EUR with a low forecast of 29.092 EUR and a high forecast of 68.53 EUR.
What is the Revenue forecast for Bristol-Myers Squibb Co?
Projected CAGR
-5%
Over the last 13 years, the compound annual growth rate for Revenue has been 8%. The projected CAGR for the next 3 years is -5%.
What is the Gross Profit forecast for Bristol-Myers Squibb Co?
Projected CAGR
-5%
Over the last 13 years, the compound annual growth rate for Gross Profit has been 8%. The projected CAGR for the next 3 years is -5%.
What is the Operating Income forecast for Bristol-Myers Squibb Co?
Projected CAGR
-5%
Over the last 13 years, the compound annual growth rate for Operating Income has been 11%. The projected CAGR for the next 3 years is -5%.
What is the Pre-Tax Income forecast for Bristol-Myers Squibb Co?
Projected CAGR
14%
Over the last 13 years, the compound annual growth rate for Pre-Tax Income has been 11%. The projected CAGR for the next 3 years is 14%.
What is the Net Income forecast for Bristol-Myers Squibb Co?
Projected CAGR
17%
Over the last 13 years, the compound annual growth rate for Net Income has been 10%. The projected CAGR for the next 3 years is 17%.
